Hyundai launches trospium chloride tablets

Published: 2008-07-15 06:52:00

Updated: 2008-07-15 06:52:00

Hyudai Pharm has launched Wismax (trospium chloride 5mg tablets), indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Trospium chloride acts as a direct antagonist at muscarinic acetylcholine receptors in cholinerg...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK